Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease
Haley, Connie A, Schechter, Marcos C, Ashkin, David, Peloquin, Charles A, Peter Cegielski, J, Andrino, Barbara B, Burgos, Marcos, Caloia, Lori A, Chen, Lisa, Colon-Semidey, Angel, DeSilva, Malini B, Dhanireddy, Shireesha, Dorman, Susan E, Dworkin, Felicia F, Hammond-Epstein, Heidi, Easton, Alice V, Gaensbauer, James T, Ghassemieh, Bijan, Gomez, Maria E, Horne, David, Jasuja, Supriya, Jones, Betsy A, Kaplan, Leonard J, Khan, Asharaf Edward, Kracen, Elizabeth, Labuda, Sarah, Landers, Karen M, Lardizabal, Alfred A, Lasley, Maria T, Letzer, David M, Lopes, Vinicius K, Lubelchek, Ronald J, Patricia Macias, C, Mihalyov, Aimee, Misch, Elizabeth Ann, Murray, Jason A, Narita, Masahiro, Nilsen, Diana M, Ninneman, Megan J, Ogawa, Lynne, Oladele, Alawode, Overman, Melissa, Ray, Susan M, Ritger, Kathleen A, Rowlinson, Marie-Claire, Sabuwala, Nadya, Schiller, Thomas M, Schwartz, Lawrence E, Spitters, Christopher, Thomson, Douglas B, Tresgallo, Rene Rico, Valois, Patrick, Goswami, Neela D
Published in Clinical infectious diseases (05.10.2023)
Published in Clinical infectious diseases (05.10.2023)
Get full text
Journal Article